Top News
Latest News
INNOVATION
25 Feb 2026
Can AI Rethink How New Drugs Are Found?PARTNERSHIPS
24 Feb 2026
Lilly Deepens AI Push in Obesity Drug RaceINVESTMENT
23 Feb 2026
Another Shot in the Obesity Gold RushMARKET TRENDS
19 Feb 2026
Precision Medicine Rises as Biomarkers Drive Change
Pfizer Steps Up Obesity Push With Metsera Deal
PARTNERSHIPS
17 Feb 2026
US drugmaker agrees multibillion-dollar acquisition to bolster metabolic pipeline and challenge leaders in weight-loss therapies
INNOVATION
25 Feb 2026
Can AI Rethink How New Drugs Are Found?
Alliance uses AI and clinical data to target IBD, dermatitis, and MS while cutting R&D risks
PARTNERSHIPS
24 Feb 2026
Lilly Deepens AI Push in Obesity Drug Race
US drugmaker expands Nimbus alliance to pursue oral therapy as analysts forecast $100bn market for weight-loss medicines
INVESTMENT
23 Feb 2026
Another Shot in the Obesity Gold Rush
A $160m funding round propels Alveus into mid-stage trials, as investors hunt for drugs that improve on today’s GLP-1 blockbusters
MARKET TRENDS
19 Feb 2026
Precision Medicine Rises as Biomarkers Drive Change
A biomarker surge is reshaping Europe’s healthcare market, driving consolidation, stricter regulation, and a push to align diagnostics wit...
PARTNERSHIPS
17 Feb 2026
Pfizer Steps Up Obesity Push With Metsera Deal
US drugmaker agrees multibillion-dollar acquisition to bolster metabolic pipeline and challenge leaders in weight-loss therapies
INSIGHTS
16 Feb 2026
AI Drugmaker Targets Obesity Beyond GLP-1
Insilico advances oral GIP candidate, signalling wider competition in weight-loss treatments
SUBSCRIBE FOR UPDATES
By submitting, you agree to receive email communications from the event organizers, including upcoming promotions and discounted tickets, news, and access to related events.